Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

16.15 +0.09 (+0.56%)
Official Closing Price Updated: 4:10 PM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
24 25 Next >
News headline image
These Dividend Stocks Fell Between 1% and 20% in 2024. Here's Why They Are Too Cheap to Ignore and Worth Buying in 2025. ↗
Via The Motley Fool
News headline image
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗
These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors. 
Via The Motley Fool
News headline image
Qorvo Soars 7% After Hours As Activist Investor Starboard Reportedly Takes Stake In Semiconductor Company ↗
Activist investor Starboard Value LP has reportedly acquired a 7.7% stake worth approximately $500 million in Qorvo Inc. on Thursday, targeting the struggling semiconductor manufacturer for potential... 
Via Benzinga
News headline image
Kenvue Declares Quarterly Cash Dividend
From Kenvue
Via Business Wire
News headline image
What Analysts Are Saying About Kenvue Stock ↗
 
Via Benzinga
News headline image
Peering Into Kenvue's Recent Short Interest ↗
 
Via Benzinga
News headline image
Critical Insights From Kenvue Analyst Ratings: What You Need To Know ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Kenvue? ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 6, 2025 ↗
 
Via Benzinga
News headline image
Kenvue Highlights Commitment to Shareholder Value
From Kenvue
Via Business Wire
News headline image
All It Takes Is $3,000 Invested in Each of These 3 Ultra-Reliable Dividend King Stocks to Help Generate Over $300 in Passive Income in 2025 ↗
Via The Motley Fool
News headline image
Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock? ↗
Via The Motley Fool
News headline image
A Look Into Kenvue Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025
From Kenvue
Via Business Wire
News headline image
In-Depth Technical Analysis of KENVUE INC. ↗
With a solid technical rating of 8 out of 10, KENVUE INC (NYSE:KVUE) is showing strong indications of a possible breakout. 
Via Chartmill
News headline image
10 One Decision Stocks To Buy Now ↗
The following 10 one decision stocks have increased their dividends for over 25 years, making them Dividend Aristocrats. 
Via Talk Markets
Topics Stocks / Equities
News headline image
10 Conservative Retirement Income Stocks To Buy Now ↗
Conservative retirement investing is all about creating passive income with quality securities, held for the long-run. 
Via Talk Markets
Topics Retirement Stocks / Equities
News headline image
3 Dividend-Paying Value Stocks to Buy Even If There's a Stock Market Sell-Off in 2025 ↗
Investing by equal parts in these three dividend stocks produces an average yield of 3%. 
Via The Motley Fool
News headline image
A Bull Market Is Here: 2 Super Stocks Down 21% and 30% to Buy Right Now ↗
Via The Motley Fool
News headline image
Coca-Cola cs. Procter & Gamble: Which Is the Better Dow Dividend King Stock to Buy Before the End of the Year? ↗
Via The Motley Fool
Topics Stocks
News headline image
Like Passive Income? Then You'll Love These 3 Super Safe Dividend Stocks That Are Up Between 28% and 42% in 6 Months. ↗
These three dividend-paying companies have all raised their payouts every year for at least 40 consecutive years. 
Via The Motley Fool
News headline image
Kenvue Announces Participation in the Morgan Stanley Global Consumer & Retail Conference
From Kenvue
Via Business Wire
News headline image
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns ↗
FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued. 
Via Benzinga
News headline image
Kenvue (KVUE) Q3 2024 Earnings Call Transcript ↗
KVUE earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin Health And Beauty Sales ↗
Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in Skin Health and Beauty. 
Via Benzinga
News headline image
Kenvue Reports Third Quarter 2024 Results
From Kenvue
Via Business Wire
News headline image
Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
From Kenvue
Via Business Wire
News headline image
This Big New Development Could Be Bullish for Kenvue Stock ↗
Can tinkering around the edges actually make this stock more attractive? 
Via The Motley Fool
News headline image
3 Dividend Stocks to Double Up on Right Now ↗
While tech-based growth stocks might seem like the right play, you can't ignore dividends if you want to have a strong portfolio. 
Via The Motley Fool
News headline image
Billionaire Ken Griffin Just Increased His Position in This Dividend Stock by 5,848%. Here's Why Now May Be a Great Time to Buy. ↗
Ken Griffin's Citadel just added 18 million shares of an under-the-radar consumer health stock. 
Via The Motley Fool
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.